dc.contributor.author
Struck, Julian P.
dc.contributor.author
Hennig, Martin J. P.
dc.contributor.author
Hupe, Marie C.
dc.contributor.author
Moharam, Nadim
dc.contributor.author
Paffenholz, Pia
dc.contributor.author
Nestler, Tim
dc.contributor.author
Frank, Tanja
dc.contributor.author
Worst, Thomas S.
dc.contributor.author
Grabbert, Markus
dc.contributor.author
Pohlmann, Philippe-Fabian
dc.contributor.author
Dogan, Serkan
dc.contributor.author
Hofbauer, Sebastian L.
dc.contributor.author
Kalogirou, Charis
dc.contributor.author
Mattigk, Angelika
dc.contributor.author
Brandt, Maximilian P.
dc.contributor.author
Krabbe, Laura-Maria
dc.contributor.author
Reis, Henning
dc.contributor.author
Dressler, Franz F.
dc.contributor.author
Kramer, Mario W.
dc.contributor.author
Salem, Johannes
dc.date.accessioned
2023-07-11T12:57:45Z
dc.date.available
2023-07-11T12:57:45Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/40048
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-39770
dc.description.abstract
Introduction: Guideline recommendations are meant to help minimize morbidity and to improve the care of nonmuscle invasive bladder cancer (NMIBC) patients but studies have suggested an underuse of guideline-recommended care. The aim of this study was to evaluate the level of adherence of German and Austrian urologists to German guideline recommendations. Methods: A survey of 27 items evaluating diagnostic and therapeutic recommendations (15 cases of strong consensus and 6 cases of consensus) for NMIBC was administered among 14 urologic training courses. Survey construction and realization followed the checklist for reporting results of internet e-surveys and was approved by an internal review board. Results: Between January 2018 and June 2019, a total of 307 urologists responded to the questionnaire, with a mean response rate of 71%. The data showed a weak role of urine cytology (54%) for initial diagnostics although it is strongly recommended by the guideline. The most frequently used supporting diagnostic tool during transurethral resection of the bladder was hexaminolevulinate (95%). Contrary to the guideline recommendation, 38% of the participants performed a second resection in the case of pTa low-grade NMIBC. Correct monitoring of Bacille Calmette-Guerin (BCG) response with cystoscopy and cytology was performed by only 34% of the urologists. Conclusions: We found a discrepancy between certain guideline recommendations and daily routine practice concerning the use of urine cytology for initial diagnostics, instillation therapy with a low monitoring rate of BCG response, and follow-up care with unnecessary second resection after pTa low-grade NMIBC in particular. Our survey showed a moderate overall adherence rate of 73%. These results demonstrate the need for sharpening awareness of German guideline recommendations by promoting more intense education of urologists to optimize NMIBC care thus decreasing morbidity and mortality rates.
en
dc.subject
Bladder cancer
en
dc.subject
Nonmuscle invasive bladder cancer
en
dc.subject
Guideline adherence
en
dc.subject
Treatment management
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1159/000518166
dcterms.bibliographicCitation.journaltitle
Urologia Internationalis
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Karger
dcterms.bibliographicCitation.pagestart
35
dcterms.bibliographicCitation.pageend
45
dcterms.bibliographicCitation.volume
107
dcterms.rightsHolder.note
Copyright applies in this work.
dcterms.rightsHolder.url
http://rightsstatements.org/vocab/InC/1.0/
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.note.author
Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
de
refubium.note.author
This publication is shared with permission of the rights owner and made freely accessible through a DFG (German Research Foundation) funded license at either an alliance or national level.
en
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34515257
dcterms.isPartOf.issn
0042-1138
dcterms.isPartOf.eissn
1423-0399